FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathwaysHaiyang Hu(Second Affiliated Hospital of Harbin Medical University), Qiang Lin(Shanghai Jiao Tong University)International Journal of Medical SciencesJanuary 1, 202010.7150/ijms.33992Cited by 52SaveCiteExport RISWatch citationsRelated PapersLipid raft localization of epidermal growth factor receptor alters matrix metalloproteinase-1 expression in SiHa cells via the MAPK/ERK signaling pathway|Oncology Letters|2016|38Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest|Oncology Reports|2016|14